Free Trial

Neogen (NEOG) Competitors

Neogen logo
$5.24 +0.26 (+5.22%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$5.23 -0.01 (-0.27%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NEOG vs. HAE, ICUI, XRAY, QDEL, STAA, CERS, OSUR, UTMD, ANIK, and WST

Should you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry.

Neogen vs. Its Competitors

Neogen (NASDAQ:NEOG) and Haemonetics (NYSE:HAE) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

Neogen presently has a consensus target price of $7.50, suggesting a potential upside of 43.13%. Haemonetics has a consensus target price of $96.80, suggesting a potential upside of 27.13%. Given Neogen's higher probable upside, analysts plainly believe Neogen is more favorable than Haemonetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neogen
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Haemonetics
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
2.91

Neogen has a beta of 1.77, suggesting that its stock price is 77% more volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.39, suggesting that its stock price is 61% less volatile than the S&P 500.

Haemonetics has a net margin of 12.32% compared to Neogen's net margin of -53.56%. Haemonetics' return on equity of 26.37% beat Neogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Neogen-53.56% 2.69% 1.82%
Haemonetics 12.32%26.37%9.22%

96.7% of Neogen shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 1.1% of Neogen shares are owned by company insiders. Comparatively, 1.8% of Haemonetics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Neogen had 5 more articles in the media than Haemonetics. MarketBeat recorded 8 mentions for Neogen and 3 mentions for Haemonetics. Haemonetics' average media sentiment score of 1.84 beat Neogen's score of 0.02 indicating that Haemonetics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Neogen
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Haemonetics
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Haemonetics has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neogen$924.22M1.23-$9.42M-$2.23-2.35
Haemonetics$1.36B2.69$167.68M$3.3123.00

Summary

Haemonetics beats Neogen on 14 of the 17 factors compared between the two stocks.

Get Neogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEOG vs. The Competition

MetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.08B$10.44B$5.47B$8.95B
Dividend YieldN/A2.08%5.25%4.04%
P/E Ratio-2.3516.3326.9920.11
Price / Sales1.2330.69428.71119.81
Price / Cash4.8622.7536.8257.86
Price / Book0.363.657.985.56
Net Income-$9.42M$235.43M$3.16B$248.40M
7 Day Performance0.19%1.38%2.38%4.67%
1 Month Performance-5.07%1.54%2.17%6.64%
1 Year Performance-64.43%-10.04%33.81%21.31%

Neogen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NEOG
Neogen
3.9578 of 5 stars
$5.24
+5.2%
$7.50
+43.1%
-65.3%$1.08B$924.22M-2.352,110
HAE
Haemonetics
4.881 of 5 stars
$74.77
+1.3%
$96.80
+29.5%
-11.1%$3.59B$1.36B22.593,023News Coverage
Positive News
ICUI
ICU Medical
4.5877 of 5 stars
$132.15
+0.3%
$192.67
+45.8%
+8.7%$3.25B$2.38B-34.5015,000Positive News
XRAY
DENTSPLY SIRONA
4.4339 of 5 stars
$15.88
-0.3%
$20.36
+28.2%
-33.0%$3.16B$3.79B-3.5014,000Positive News
QDEL
QuidelOrtho
4.432 of 5 stars
$28.82
-0.2%
$44.33
+53.8%
+1.5%$1.95B$2.78B-5.806,600
STAA
STAAR Surgical
4.1102 of 5 stars
$16.78
-0.8%
$24.63
+46.8%
-60.8%$831.11M$313.90M-11.651,211
CERS
Cerus
3.339 of 5 stars
$1.41
-0.7%
$3.50
+148.2%
-25.5%$269.54M$180.27M-14.10290
OSUR
OraSure Technologies
1.8231 of 5 stars
$3.00
-0.3%
$3.00
-25.7%$224.40M$185.83M-7.14840News Coverage
UTMD
Utah Medical Products
1.8474 of 5 stars
$56.92
-1.5%
N/A-13.2%$184.99M$40.90M15.06180News Coverage
Positive News
ANIK
Anika Therapeutics
3.7375 of 5 stars
$10.58
-1.5%
$20.00
+89.0%
-57.4%$151.72M$119.91M-2.73300Positive News
WST
West Pharmaceutical Services
4.7535 of 5 stars
$218.80
0.0%
$320.00
+46.3%
-31.0%$15.72B$2.89B34.3510,600Trending News

Related Companies and Tools


This page (NASDAQ:NEOG) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners